Read news on Sarcoma with our app.
Read more in the app
Immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma
Sarcoma clinical trial funded by stand up to cancer reduces risk of relapse by 43% - EurekAlert